secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuronetics, Inc. (STIM)
CIK:        0001227636
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001193125-26-044912
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuronetics reports preliminary Q4 2025 revenue $41.8M, up 23% pro forma; positive operating cash flow
--------------------------------------------------------------------------------

- Q4 revenue $41.8M, 23% YoY pro forma growth; NeuroStar revenue $18.3M (+9% pro forma).
- Full year 2025 revenue $149.2M, 15% pro forma growth; clinic revenue $87.0M (+28% pro forma).
- Q4 operating cash flow positive $0.9M; total cash $34.1M at year-end.
- 49 NeuroStar systems shipped in Q4.
- Final Q4 results to be released March 17, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1227636/000119312526044912/0001193125-26-044912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1227636/000119312526044912/d109652d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-044912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer